| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Do | Evotec streicht 800 Stellen - und trotzdem sehen Analysten 100% Kurspotenzial | 1.446 | ARIVA.de | 800 Stellen weg, Kosten explodiert, Gewinne verschoben - Evotec steckt tief in der Krise. Doch Analysten sehen mehr als 100% Kurspotenzial. Was steckt hinter dem Widerspruch? Rund 800 Stellen werden... ► Artikel lesen | |
| Do | Dermata Therapeutics Provides Corporate Update and Reports Financial Results for the Year Ended 2025 | 1.296 | ACCESS Newswire | - Dermata announced a strategic pivot to develop and commercialize direct-to-consumer ("DTC") skincare products under the brand name Tome -- Dermata plans to launch its first DTC product, our Foundational... ► Artikel lesen | |
| Do | Pulmatrix Inc.: Pulmatrix and Eos SENOLYTIX Announce Merger Agreement to Advance Novel Mitochondrial Therapies to Improve Healthspan | 851 | PR Newswire | Combined company to operate as Eos SENOLYTIX, a first-in-class anti-aging biotechnology company
$19 million financings to advance lead clinical candidate PTC-2105 for sarcopenia and... ► Artikel lesen | |
| Do | ViroGates A/S: ViroGates announces its Annual Report 2025: Revenue growth and improved operating result as strategic transition towards preventive health and longevity continues | 618 | GlobeNewswire (Europe) | Company Announcement no. 1/2026 (March 26, 2026 at 15:10:00 CET)
Inside information
BIRKERØD, DENMARK ViroGates A/S ("ViroGates" or "Company"), a medical technology company developing blood tests for... ► Artikel lesen | |
| Do | Aktien New York Ausblick: Schwach erwartet - Iran-Krieg bleibt im Fokus | 533 | dpa-AFX | NEW YORK (dpa-AFX) - Die moderate Erholung der US-Börsen zur Wochenmitte dürfte am Donnerstag wieder zunichtegemacht werden. Die Unsicherheiten rund um den Iran-Krieg drücken weltweit auf die Stimmung... ► Artikel lesen | |
| Do | EQS-News: Wall Street Wire: Verteidigungsboom trifft Biotech - MediWound könnte zu den unterschätzten Profiteuren zählen (NASDAQ: MDWD) | 401 | EQS Group (DE) | EQS-News: Wall Street Wire
/ Schlagwort(e): Sonstiges
Verteidigungsboom trifft Biotech - MediWound könnte zu den unterschätzten Profiteuren zählen (NASDAQ: MDWD)
26.03.2026... ► Artikel lesen | |
| Do | DBV Technologies S.A.: DBV Technologies Reports Full Year 2025 Financial Results and Business Update | 382 | GlobeNewswire (Europe) | Châtillon, France, March 26, 2026
DBV Technologies Reports Full Year 2025 Financial Results and Business Update
Continued advancing the VIASKIN Peanut Patch clinical development programs in... ► Artikel lesen | |
| Do | DBV Technologies S.A.: DBV Technologies Announces Filing of 2025 Annual Report on Form 10-K and Universal Registration Document | 365 | GlobeNewswire (Europe) | Châtillon, France, March 26, 2026
DBV Technologies Announces Filing of 2025 Annual Report on Form 10-K and Universal Registration Document
DBV Technologies (Euronext: DBV - ISIN: FR0010417345... ► Artikel lesen | |
| Do | XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 26.03.2026 | 358 | Xetra Newsboard | The following instruments on Boerse Frankfurt do have their last trading day on 26.03.2026.Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 26.03.2026.ISIN NameCA2568277834 DOLLY... ► Artikel lesen | |
| 01:06 | Biocytogen Pharmaceuticals (Beijing) Co., Ltd.: Biocytogen Announces FDA IND Clearance for Partner NEOK Bio's NEOK002 Targeting Solid Tumors | 351 | Business Wire | Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (Biocytogen, SSE: 688796; HKEX: 02315), a global biotechnology company that drives the research and development of novel antibody-based drugs with innovative... ► Artikel lesen | |
| Do | BioInvent International: BioInvent Achieves Phase 3 Milestone for HMI-115 in Endometriosis | 331 | ACCESS Newswire | BioInvent International (STO:BINV) - Achievement of the milestone triggers a payment of € 1 million LUND, SE / ACCESS Newswire / March 26, 2026 / BioInvent International AB ("BioInvent") (Nasdaq Stockholm:BINV)... ► Artikel lesen | |
| Do | Galapagos NV: Galapagos Publishes 2025 Annual Report and Announces Annual and Extraordinary Shareholders' Meetings | 330 | GlobeNewswire (Europe) | Mechelen, Belgium; March 26, 2026, 21:01 CET; regulated information - Galapagos NV (Euronext & NASDAQ: GLPG) today published its annual report for the financial year 2025 and announced that its Annual... ► Artikel lesen | |
| Do | NurExone stellt Weichen für Wachstum und Sichtbarkeit | Small- & Micro Cap Investment | |||
| Do | Sino Biopharmaceutical Limited: Sino Biopharm (1177.HK) Announces 2025 Annual Results | 267 | JCN Newswire | - Innovation and R&D Advance Steadily, RMB 31.83 Billion in Revenue Recorded- Underlying Profit Attributable to Owners of the Parent of RMB 4.54 Billion RecordedHONG KONG, Mar 26, 2026 - (ACN Newswire)... ► Artikel lesen | |
| Do | EIB Waives its Right to Cash Settlement on Medincell Warrants | 266 | Business Wire | The European Investment Bank (EIB) has waived the put option attached to the warrants granted in connection with the €40 million financing agreement signed in 2022 This waiver eliminates any... ► Artikel lesen |
| Unternehmen / Aktien | Kurs | Dividende 12M | Div.-Rendite | Erw. Dividende | Erw. Ex.-Datum | |
|---|---|---|---|---|---|---|
| BB BIOTECH | 47,000 | 2,47 | +5,26 % | 2,25 | 23.03.2026 | |
| CSL | 84,81 | 2,61 | +3,08 % | 1,84 | 10.03.2026 | |
| BML | 22,600 | 0,65 | +2,88 % | 60,00 | 30.03.2026 | |
| AMGEN | 309,30 | 8,33 | +2,69 % | 2,52 | 15.05.2026 | |
| NOVONESIS | 50,74 | 0,87 | +1,71 % | 4,25 | 20.03.2026 | |
| GENUS | 29,000 | 0,38 | +1,31 % | 0,11 | 05.03.2026 | |
| STRYKER | 290,40 | 2,97 | +1,02 % | 0,88 | 31.03.2026 | |
| BIOMERIEUX | 90,00 | 0,90 | +1,00 % | 0,98 | 09.06.2026 | |
| BIO-TECHNE | 45,400 | 0,27 | +0,59 % | 0,08 | 13.02.2026 | |
| REGENERON PHARMACEUTICALS | 659,00 | 3,02 | +0,46 % | 0,94 | 20.02.2026 |